Cross Icon

Press Releases

Your source for Evernorth news.

Cross Icon
Featured

Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year

  • Estimated to save individual Accredo patients around $4,000 per year
  • Biosimilar price will be more than 80% lower than Stelara list price
  • Accredo patients benefit from the specialty pharmacy’s best-in-class clinical support
Read more
""

Filter Press Releases

Media contact:

media@evernorth.com
Press Release
woman holding prescription

Express Scripts by Evernorth Members Paid Less for Their Share of Prescriptions in 2023 Despite Drug Price Increases

Members with employer-sponsored insurance saw about a 1% decrease in their portion out-of-pocket costs for their prescription medicines last year, paying an average of $15.10 for a 30-day supply

June 19, 24

Read More
Press Release
pharmacist

Express Scripts enhances strategies to support access to care at independent pharmacies

Based on guidance from its Independent Pharmacy Advisory Committee, Express Scripts will collaborate with CPESN ® USA through its IndependentRx initiative.

May 23, 24

Read More
Press Release
""

Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June

April 25, 24

Read More
Press Release
Patient and Counselor

Evernorth’s New Behavioral Care Practice Offers Quality Care To Improve Mental Well-Being

Evernorth is launching an outpatient behavioral health practice to expand access to quality, in-network therapy for millions of people.

March 07, 24

Read More
Press Release
Woman running

Evernorth Announces Industry-First Financial Guarantee For GLP-1 Spend

EncircleRx solution now includes financial predictability for health plan sponsors to help expand access for appropriate patients.

March 07, 24

Read More